2025 PRESENTING COMPANIES
WEDNESDAY, MARCH 19, 2025 | AUSTIN CONVENTION CENTER
2025 PRESENTING COMPANIES
WEDNESDAY, MARCH 19, 2025 | AUSTIN CONVENTION CENTER
Drew Taylor, PhD
CEO
With offices in Toronto, Canada and Los Angeles, U.S., Acorn Biolabs is a next-generation personalized regenerative medicine company with services currently offered at partner clinic locations across North America. Acorn has developed the world’s first non-invasive, follicle-based cell cryopreservation service and has patented cell-based treatments made from a patient’s own hair follicle cells. Learn more at www.acorn.me
MaryAnn Guerra
CEO
Presenter TBD
ALASTIN Skincare® is the complete skin rejuvenation approach for enhancing aesthetic procedures and restoring skin health daily—our science-centered formulations support patients on their journey to achieving healthy, more youthful-looking skin.
Presenter TBD
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
Bradford Conlon
CEO
Bimini Health Tech provides targeted bio-therapeutic solutions in plastic surgery and regenerative medicine. Since 2013, Bimini has developed, acquired, and commercialized innovative products that offer patients and physicians premium care options. The Bimini Health Tech portfolio includes the brands Healeon®, Kerastem®, Dermapose®, Puregraft® Fat Transfer, Puregraft® Essence ADM, and now the Serene Breast Implant.
Steve Kreider
Brisbane, California-based Cutera, Inc. is a leading provider of aesthetic and dermatology solutions for practitioners globally. For over 25 years, Cutera continues to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.
Murray Jenson
Managing Director
Carlos Pinto
CEO
Paul Herchman
CEO
GetHairMD offers a turn key program to treat hair-loss consisting of proven technologies , products and services that are evaluated and selected by a Clinical Advisory Board lead by Plastics Surgeons; Barry DiBernardo , Jason Pozner and Ben Tittle.
The unique business model awards protected geographical territories which are the actual property of the participating physician. GetHairMD’s goal is to ultimately be one of the most trusted brands in treating hair-loss and is building a B2C platform along with recognized Brand Ambassadors, for which the profits from patients residing in established territories will be shared with participating physicians.
Houman Hemmati, MD, PhD
Chief Medical Officer
Levation Pharma, Ltd. is an Israeli-American company that was founded on the basis of intellectual property licensed from its Founders and relating to the treatment of Acquired Blepharoptosis. Acquired Blepharoptosis is a condition in which the upper eyelids droop. Though this condition is occasionally seen in association with serious diseases, the majority of patients develop the condition as part of the natural aging process. Some patients with this condition may complain of reduced vision. For those experiencing reduced vision, it may be narrowing of their visual fields or field-of-view especially when looking up. Other patients may complain of an appearance of an elderly eye or face or being fatigued or sleep deprived. Some patients seek treatment for their visual field defects and others seek treatment simply for cosmetic purposes.
Laura Ellis, MD
Founder
The LevEllis Group will manufacture and distribute a novel and disruptive topical human growth factor product for at home use, for sale through medical offices as professional strength and and DTC at a lesser strength.
Sean Shapiro
Chief Commercial Officer
MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, NC, is an emerging leader in the healthcare industry. MedShift is one of the largest and fastest growing solution providers to the aesthetic industry and is differentiated by its technology and software as a service focus. The company brings opportunities to drive growth and scale to medical device manufacturers as well as individual medical providers across various markets, including Dermatology, Gynecology, Plastic Surgery, and MedSpa. MedShift's business is centered around four business lines, Specialty Device Subscription Financing, Pulse Connected Product (an IoT product offering), Velocity Technology Suite (Enterprise Software as a Service), and the MedShift Store, an online marketplace featuring a range of complementary products and services that streamline the complex supply-and-demand landscape of
device consumables and injectables. MedShift's mission is to drive business transformation and power sales through the use of modern technology. The company currently has partnered with over 25 aesthetic manufacturers and distributors, a portfolio of 113 devices, and over 2,300 customers.
Presenter TBD
We have been family-owned since 1908 and treat customers, patients and employees like family. It drives our unique connection with health care professionals, and it’s what makes their success our success. For us it’s personal — listening, advising, supporting and celebrating them as we pursue a shared vision to help the world look better, feel better and live better.
We are a leading, global aesthetics business, and our award-winning portfolio of injectables, devices and skin care products help health care professionals fuel confidence through aesthetic medicine.
Steven Cohen, MD, FACS
Founder
Jeff Ehrhardt
SVP, General Manager North America
James Hartman
President & CEO
Alon Bloomenfeld
CEO
Raziel Therapeutics is a clinical-stage pharmaceutical company developing RZL-012, an injectable New Chemical Entity (NCE), for fat related disorders and Aesthetic indications. RZL-012 exerts its effect via a single multi-injection session in which the compound is injected into subcutaneous fat tissue. The product is capable of killing fat cells, resulting in fat volume reduction and improved dimensions at the treated areas.
Raziel completed enrollment for a US double blind placebo-controlled phase 2b trial (N=150) in subjects seeking submental fat (SMF) reduction. Study results are expected in May 2022. SMF phase 3 studies will initiate by the end of 2022.
Another double blind placebo-controlled phase 2a study is ongoing, testing the effect of RZL-012 on fat reduction in the flanks. Results are expected in July 2022.
Raziel signed a license agreement with Fosun Pharma for RZL-012 commercialization in the big China area.
John Oakley
CEO & Director
Alisa Lask
CEO
Rion Aesthetics is a regenerative aesthetics company, founded in Rochester, Minnesota, pioneering the use of platelet-derived exosome technology in investigational studies for hair restoration and facial wrinkles. Backed by over 15 years of visionary science, we aim to transform the regenerative aesthetics market to bring beauty from within.
Our passion for aesthetics and core value of helping people achieve their aesthetic goals is reflected in our robust product portfolio and pipeline. We have investigational studies currently underway for hair restoration and facial wrinkles for potential FDA indications.
From this investigational research, we also discovered the benefits of platelet extract on skin health. Through the launch of ( plated )™ Skin Science, we will transform the skincare market using our revolutionary Renewosome™ technology from platelet extract to help rejuvenate the skin.
Andy Balk
Lead Engineer
Philippe Schaison
CEO
Presenter TBD
Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients’ lives. With unrivaled safety, state-of-the-art science and exceptional service, our portfolio of proprietary innovations radically advances how plastic surgeons care for their patients.
Dina Elsherif
CEO
Dave Heagy
CEO
Dom Serafino
CEO
Ulvera AI is dedicated to be a game changer in the field of non invasive body contouring Our quasi-focused Ultrasound technology with EMS offers effective circumference reduction, lipolysis, skin tightening and muscle stimulation in one device all in one. The technology offers a short, not painful treatment for fat reduction and skin tightening with remarkable clinical, ultrasound and pathological results.